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Unfolded protein response (UPR) is crucial for both survival and death of mammalian 
cells, which is regulated by reactive oxygen species (ROS) and nutrient depletion. In 
this study, we demonstrated the effect of ROS-accumulation, induced by β-phenethyl 
isothiocyanate (PEITC), on UPR-mediated apoptosis in ovarian cancer cells. We used 
ovarian cancer cell lines, PA-1 and SKOV-3, with different p53 status (wild- and null-type, 
respectively). PEITC caused increased ROS-accumulation and inhibited proliferation 
selectively in ovarian cancer cells, and glutathione (GSH) depletion in SKOV-3. However, 
PEITC did not cause any effect in normal ovarian epithelial cells and peripheral blood 
mononuclear cells. After 48 h of PEITC treatment (5 μM), apoptotic cell death was shown 
to increase significantly in the ovarian cancer cells and not in the normal cells. The key 
regulator of UPR-mediated apoptosis, CHOP/GADD153 and endoplasmic reticulum 
resident chaperone BiP/GRP78 were parallely up-regulated with activation of two major 
sensors of the UPR [PERK and ATF-6 in PA-1; PERK, and IRE1α in SKOV-3) in response 
to ROS accumulation induced by PEITC (5 μM). ROS scavenger, N-acetyl-L-cysteine 
(NAC), attenuated the effect of PEITC on UPR signatures (P-PERK, IRE1α, CHOP/
GADD153, and BiP/GRP78), suggesting the involvement of ROS in UPR-mediated 
apoptosis. Altogether, PEITC induces UPR-mediated apoptosis in ovarian cancer cells 
via accumulation of ROS in a cancer-specific manner.
Keywords: unfolded protein response, β-phenethyl isothiocyanate, ovarian cancer, reactive oxygen species, 
apoptosis
introduction
Ovarian cancer is the second most common gynecological malignancy worldwide and fifth lead-
ing cause of death in women in the United States (1). About 80% of women are diagnosed at the 
advanced-stage of the disease and therefore have poor prognosis. The 5-year survival rate is 30% or 
less for patients with advanced disease (2, 3). This fatality is due to frequent recurrence and resistance 
to chemotherapy (4–6). Chemoresistant cells are shown to evade cell death signals in some types of 
malignancies through metabolic alterations and/or by some currently unknown mechanisms (7, 8).
The endoplasmic reticulum (ER) is the major protein-folding site in eukaryotic cells and is con-
stantly involved with protein processing in cancer cells. The accumulation of unfolded or misfolded 
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proteins causes ER stress and activation of the unfolded protein 
response (UPR), which is crucial for the determination of cell 
survival or death under conditions of stress (9–11). Under normal 
circumstances, the UPR carries out its activities using three major 
sensors, pancreatic ER kinase (PKR)-like ER kinase (PERK), 
activating transcription factor-6 (ATF-6), and inositol-requiring 
enzyme 1 (IRE1) in an interactive manner (12). PERK performs 
dual roles by phosphorylation of eukaryotic initiation factor 2α 
(eIF2α) and can either induce the pro-apoptotic pathway (13) 
and/or can form autophagosomes (14). ATF-6 primarily performs 
a regulatory role through the transcription of ER protein chaper-
ones (15) such as binding of the immunoglobulin protein (BiP), 
also known as 78 kDa glucose-regulated protein (GRP78) (16). 
On the other hand, IRE1 with tumor-necrosis factor receptor-
associated factor 2 (TRAF2) activates c-Jun N-terminal kinase 
(JNK) to promote apoptosis (17). Out of the signaling molecules 
downstream of the UPR sensors, CCAAT/enhancer-binding pro-
tein homologous protein (CHOP), also known as growth-arrest 
and DNA-damage-inducible gene 153 (GADD153), is considered 
as an essential factor to mediate ER stress-induced apoptosis (18). 
ER stress-induced autophagy may lead to either cell survival 
or cell death. As a survival mechanism, autophagy degrades 
unfolded and misfolded proteins and recycles them. Although, 
when long-term ER stress overwhelms protein folding capacity, 
cell death is activated by apoptotic or non-apoptotic means, while 
autophagy remains as an active process (11, 12, 19). However, 
reducing the level of ER stress in different metabolic diseases may 
also have therapeutic potential, stringent activation of ER stress 
may be helpful in fighting against cancer (20).
Reactive oxygen species (ROS) have recently been considered 
as central regulators of ER function, especially in UPR signaling in 
various diseases, including cancer (21). Such ROS-mediated UPR 
could lead to apoptosis through the activation of PERK. In addi-
tion to its canonical function, PERK also physically interacts with 
mitochondria-associated membrane (MAM) to regulate inter-
organellar crosstalk in ROS-induced cell death (22). ROS have a 
dual role inside cells. In cancer cells, durable ROS determine cell 
survival by inducing several survival pathways responsible for cell 
proliferation, apoptosis suppression, cell migration, and invasion, 
as well as suppression of the immune system. High ROS levels, 
however, can be toxic to cancer cells and lead to cell death (23). 
As demonstrated by previous studies, the levels of ROS around 
threshold could determine cell fate to go death or survival and 
this could be target for cancer therapy.
Several recent studies suggest that dietary phytochemicals 
may offer a chemo-preventive effect against many types of malig-
nancies (24). Furthermore, epidemiological evidence showed 
that there is an inverse relationship between the intake amount 
of dietary isothiocyanates (ITCs) and cancer risk (25, 26). Among 
all the ITCs, β-phenethyl isothiocyanate (PEITC) has reached the 
level of phase 2 clinical trials for lung and oral cancer preven-
tion (27, 28). PEITC is a well-known phytochemical found in 
its glucosinolate precursor form in cruciferous vegetables such 
as watercress and broccoli (27, 29). Due to its potential use in 
preventive medicine and as a cancer therapeutic agent, PEITC has 
gained the attention and interest of the cancer research commu-
nity worldwide (27). This particular ITC is a potent generator of 
ROS (30, 31), and it was previously reported that increased levels 
of ROS may activate UPR-induced cell death in cancer cells (32). 
However, PEITC-induced ROS-UPR-mediated killing of ovarian 
cancer cells has not yet been evaluated.
As such, the present study was conducted to explore the effects 
of PEITC on UPR-mediated cellular death in ovarian cancer cells.
Materials and Methods
reagents and antibodies
Propidium iodide (PI), N-acetyl-L-cysteine (NAC), DCFH-DA 
(6-carboxy-2,7-dichlorodihydrofluorescein diacetate), and 
PEITC were purchased from Sigma Aldrich (St. Louis, MO, USA) 
and MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium 
bromide) from Amresco (Solon, OH, USA). Fluorescein iso-
thiocyanate (FITC)-labeled annexin V (Annexin V-FITC) kit was 
obtained from BD Biosciences Pharmingen (San Diego, CA, USA). 
Antibodies against ATF-6 and IRE1α were purchased from Cell 
Signaling Technology (CA), P-PERK, CHOP/GADD153, and poly-
ADP ribose polymerase (PARP) from Santa Cruz Biotechnology 
(CA), BiP/GRP78 from BD Transduction LaboratoriesTM, and 
GAPDH from AbFrontier (Seoul, South Korea).
cell culture
Human ovarian cancer cell lines PA-1 (p53 wild type) and SKOV-3 
(p53 null type) were purchased from the American Type Culture 
Collection (Rockville, MD, USA). PA-1 cells were maintained in 
MEM and SKOV-3 cells were maintained in RPMI 1640 media. 
All of the media was supplemented with 10% fetal bovine serum 
(FBS) (Gibco BRL, Life Technologies, Grand Island, NY, USA), 
100  mg/ml penicillin/streptomycin (P/S) (Gibco), and main-
tained in cell culture dishes (SPL, Seoul, South Korea) at 37°C in 
a humidified atmosphere with 5% CO2.
Primary culture of human Ovarian  
surface epithelial cells
Human ovarian surface tissues were obtained from non-malignant 
patients from Seoul National University Hospital (Seoul, South 
Korea) with Institutional Review Board (IRB) approval (C-1307-
008-502). Tissues were gently washed in PBS (Gibco-BRL, 
Gaithersburg, MD, USA) and placed in a petri dish with surface 
cortex tissue facing down. Dispase (Gibco, Life Technologies) was 
then added at a concentration of 2.4 U/ml in PBS and incubated 
overnight at 4°C. Tissue surfaces were gently scrubbed to collect 
isolated cells and washed in PBS at 500 g for 4 min in 25°C. The 
pellet was suspended in 1:1 mixture of MCDB105 (Gibco, Life 
Technologies) and M199 (Sigma-Aldrich) and cultured in 35 mm 
dishes as described above. Cells up to passage three were used for 
the experiments.
isolation of Peripheral Blood Mononuclear cells
Isolation of peripheral blood mononuclear cells (PBMCs) from 
the buffy coat was modified from a previously described method 
(33, 34). Briefly, the buffy coat was diluted in PBS (1:1) and slowly 
layered on top of Ficoll-PlaqueTM–Premium (GE healthcare, 
Sweden) followed by centrifugation at 400 × g for 30 min at 20°C. 
The PBMC layer was isolated carefully and washed two times with 
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PBS (200 g for 15 min at 20°C). The isolated cells were counted, 
and then resuspended in RPMI 1640 media supplemented 
with 10% FBS and 100  mg/ml penicillin/streptomycin. About 
2×106 cells/ml were cultured in 5 ml polystyrene round bottom 
tubes (BD Biosciences) and incubated as described above. This 
study was carried out in accordance with the protocol approved 
by IRB of Seoul National University Hospital (C-1307-008-502).
Measurement of intracellular rOs
2′7′-dichlorodihydrofluorescein diacetate (DCFH-DA; Sigma 
Aldrich) was used to measure intracellular ROS. DCFH-DA is 
cleaved by esterase to DCFH, which is oxidized by hydrogen per-
oxide to form DCF. After exposure to PEITC for 0, 12, and 24 h, 
the exposed cancer cells were incubated in medium with 25 μM 
DCFH-DA for a total of 30 min with vortexing every 10 min at 
37°C in the dark. Relative fluorescence intensity of DCF (green) 
was measured using a BD FACS Canto II flow cytometer. DCF 
fluorescence was measured with excitation at 488 nm and emis-
sion at 525 nm. To confirm the generation of intracellular ROS, 
cells were pretreated for 1  h with 10  mM N-acetyl-L-cysteine 
(NAC; a hydrogen peroxide scavenger) as a negative control prior 
to treatment with PEITC.
glutathione assay
Glutathione depletion was measured using glutathione assay 
kit according to manufacturer instructions (Cayman Chemical, 
Ann Arbor, MI, USA). Briefly, cells were collected with a rub-
ber policeman and homogenized in cold buffer (50  mM MES 
buffer, pH 6–7, containing 1 mM EDTA). After centrifugation at 
10,000 × g for 15 min at 4°C, an equal volume of the MPA reagent 
(5 g of metaphosphoric acid in 50 ml water, Sigma-Aldrich) was 
added to the sample and mixed by vortexing for deproteination. 
The mixture was incubated at room temperature for 5 min, and 
centrifuged at >2000 × g for 2 min. The supernatant was collected 
for glutathione detection. A standard curve was prepared for the 
measurement of glutathione level in the samples.
cell Proliferation assay
The effect of PEITC on cell proliferation was determined by MTT 
(3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bro-
mide) assay as described previously (35). In brief, SKOV-3 and 
PA-1 cells were plated onto 96-well plates at a density between 
700 and 3000 cells per well, respectively. The cells were cultured 
for 24 and 48 h with various concentrations of PEITC (0, 1, 2.5, 5, 
10, 20, and 40 μM) dissolved in DMSO. Cells were incubated with 
50 μl of MTT solution (2 mg/ml) for 3 h at 37°C in the dark. MTT 
was then removed and cells were solubilized in 100 μl DMSO for 
30 min on a shaker. The optical density was measured at 540 nm 
using a spectrophotometer (Labsystems Multiskan, Labsystems, 
Helsinki, Finland).
Detection of apoptotic cells by Flow cytometry
Cells were collected by trypsinization with 0.05% Trypsin-EDTA 
and washed twice with cold PBS. To include the floating cells, 
prior to trypsinization, culture medium was collected and floaters 
were spun down by centrifugation in FACS tubes (BD Falcon, CA, 
USA) at 4°C for 5 min. The cells were then stained with annexin 
V-FITC and PI according to the manufacturer’s instructions (BD 
Pharmingen, CA, USA) on ice. Cells were then analyzed by flow 
cytometry (BD FACSCanto II) within 1 h.
Western Blotting
Western blotting was performed according to methods described 
in a previous study (35) with minor modifications. In brief, after 
PEITC treatment, ovarian cancer cells were collected and washed 
with PBS and trypsinized with 0.05% Trypsin-EDTA. Cell lysates 
were prepared as described previously (34). Protein quantitative 
analysis was determined using a BCA assay kit (Thermo Scientific, 
Hudson, NH, USA). Cell lysates with 20 μg of protein were loaded 
onto gels and subjected to 6–15% SDS-PAGE. Proteins were then 
transferred to a nitrocellulose membrane and blocked with 5% 
skim milk in tris-buffered saline (TBS) containing 0.1% Tween-20 
for 2 h. The membrane was then incubated with specific primary 
antibodies overnight at 4°C, and then incubated with peroxidase-
conjugated secondary antibodies. Signals were visualized using a 
chemiluminescence detection kit (AbFrontier, Seoul, South Korea).
statistical analysis
All of the experiments were performed in 3–5 replicates and the 
data expressed as means ±  SEM. Student’s t-test and ANOVA 
with Bonferroni’s post  hoc test were performed for statistical 
comparison. GraphPad Prism 5 and statistical software SPSS 20.0 
(SPSS Inc., Chicago, IL, USA) were used for the analyses. P-value 
<0.05 was considered statistically significant.
results
PeiTc inhibits growth of Ovarian cancer 
cells without inhibiting the growth of 
normal PBMc cells
Phenethyl isothiocyanate is well recognized for its anti-prolifera-
tive activity (28). To determine the effect of PEITC on the growth 
of normal cells, we performed an MTT assay with concentrations 
ranging from 1 to 40 μM. Selected doses of PEITC were also 
tested on normal PBMCs. Both PA-1 and SKOV-3 cells showed 
significant inhibition of cell proliferation upon PEITC treatment 
in a dose- and time- dependent manner. Dose–response curve fit-
ting determined the IC50 values of PA-1 and SKOV-3 cell lines to 
be 5.09 and 4.67 μM, respectively, after 48 h of PEITC treatment. 
To determine the effect of PEITC on normal PBMCs, cells were 
treated with 5 and 10 μM concentrations of PEITC. We found no 
significant effect after 24 or 48 h of treatment thereby, suggesting 
a cancer cell-specific inhibitory effect of PEITC (Figure 1).
PeiTc Triggers rOs accumulation in  
Ovarian cancer cells
We evaluated the effect of PEITC on ROS generation in ovarian 
cancer cell lines, PA-1 and SKOV-3, by flow cytometry using 
25  μM DCFH-DA. We chose to use normal ovarian surface 
epithelial cells (OSE) as a control. The results showed an increase 
of ROS in ovarian cancer cells with no effect on normal OSE. 
In PA-1 cells, the increase of ROS was significantly high at both 
12 and 24  h after PEITC treatment. Increased ROS were also 
observed in SKOV-3 cells; however, it was significant only after 
July 2015 | Volume 5 | Article 1674
Hong et al. PEITC-induced UPR in ovarian cancer
Frontiers in Oncology | www.frontiersin.org
24  h of PEITC treatment. In addition, ROS accumulation was 
higher at 24  h in SKOV-3 cells compared to that in PA-1 cells 
(Figure  2A). Then we evaluated GSH level following PEITC 
treatment. PEITC significantly depleted GSH level in SKOV-3. 
However, PEITC did not have significant effect on GSH depletion 
in PA-1 (Figure 2B). Thus, PEITC induces ROS in ovarian cancer 
cell lines in different mechanism.
PeiTc induces apoptotic cell Death in  
Ovarian cancer cell lines
In Figure 3, we showed PEITC-induced apoptotic cell death in 
PA-1 and SKOV-3 cells using the criteria of positive Annexin 
V-PI staining and PARP cleavage. In PA-1 cells, no significant 
apoptotic cell death was observed by Annexin V-PI staining after 
24 h but, it was significant (up to 10%) after 48 h of treatment. 
On the other hand, in SKOV-3 cells, we observed more than 10% 
cell death after 24 h and more than 20% after 48 h (Figure 3A). 
Western blot analysis revealed that the cleaved fragment of PARP 
was slightly increased in PA-1 cells after 24 h of PEITC treatment, 
but it was more prominent in SKOV-3 cells (Figure 3B). These 
data suggest that upon PEITC exposure, ovarian cancer cell line 
PA-1is more resistant to apoptotic cell death than SKOV-3.
rOs scavenger, N-acetyl-L-cysteine (nac), 
reverses PeiTc-induced cell Death in  
Ovarian cancer cells
To determine whether PEITC induced cell death is mediated 
by ROS or not, we treated cells with the ROS scavenger, NAC, 
FigUre 1 | inhibitory effect of PeiTc on growth of ovarian cancer 
cells with no effect on that of normal peripheral blood mononuclear 
cells (PBMcs). Ovarian cancer cell lines were incubated with vehicle and 
various concentrations of PEITC (1, 2, 5, 10, 20, and 40 μM) for 24 or 48 h. 
PA-1, and SKOV-3 cells were plated onto 96-well plates at a density  
between 700 and 3000 cells per well, respectively. Normal PBMC were 
treated with selected concentrations of PEITC (5 and 10 μM). Cellular 
proliferative activity was measured by MTT assay (a,B). Corresponding IC50 
value against each cell line after 24 and 48 h of PEITC treatment is 
presented in the table (c).
alone or in a combination with PEITC for 24 h. For SKOV-3 cells, 
PEITC-induced cell death was above 10%, while NAC reduced 
the cell death to less than 5% (Figure 4A). PARP cleavage was 
consistent with the Annexin V-PI data, where cleaved PARP was 
detected upon PEITC treatment, and eliminated with the addition 
of NAC (Figures 4B,C). In PA-1 cells, cell death determined by 
Annexin V-PI staining was not significant for any treatment group 
(Figure 4A). However, although cleaved PARP was observed in 
PEITC-treated cells alone, it was subsequently abolished in cells 
pretreated with NAC (Figures 4B,C).
PeiTc induces Unfolded Protein response, 
attenuated by nac, in Ovarian cancer cells
To determine whether PEITC induces the UPR, we investigated 
several crucial UPR markers namely P-PERK, ATF-6, inositol-
requiring enzyme 1α (IRE1α), CHOP/GADD153, and molecular 
chaperone BiP/GRP78. In a time-dependent manner, two major 
arms of UPR (P-PERK and ATF-6) were found to be activated in 
SKOV-3 cell line (with null type p53), whereas ATF-6 and PERK 
were activated in PA-1 cells (with wild-type p53). Interestingly, 
IRE1α was decreased time dependently in PA-1 cells. However, 
expression levels of downstream target molecules, CHOP/
GADD153 and BiP/GRP78, were increased in both cell lines, 
suggesting an activated ER stress-mediated UPR response 
with PEITC treatment (Figure 5A). To determine whether this 
response is ROS related or not, we treated cells with the ROS 
scavenger, NAC for 24 h (a time point when UPR response was 
the highest). We found an attenuating effect of NAC for P-PERK, 
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IRE1α, and downstream molecules CHOP/GADD153 and BiP/
GRP78 in SKOV-3 cells. In PA-1 cells, NAC treatment also reduced 
PEITC-induced expression of P-PERK, ATF6, CHOP/GADD153, 
and BiP/GRP78 (Figure 5B). Western blot bands were quantified 
and displayed as bar graphs (Figures  5C,D). Altogether, UPR 
activation by PEITC is likely mediated by ROS in ovarian cancer.
Discussion
In the present study, PEITC treatment induced activation of UPR 
and apoptotic cell death in SKOV-3 and PA-1 ovarian cancer 
cell lines. PA-1 was more resistant to the induction of UPR and 
apoptosis, than SKOV-3 cells. Addition of antioxidant, NAC, 
with PEITC suppressed the UPR and apoptosis in both cell lines, 
especially SKOV-3. PEITC also induced generation of ROS and 
potent anti-proliferative activity in these cell lines with no signifi-
cant effect on normal OSE. These results suggest that PEITC may 
have selectively anticancer effect on ovarian cancer cells through 
ROS-mediated UPR.
The anti-proliferative effect of PEITC on cancer cells is well 
documented. It has been observed that PEITC inhibits prolifera-
tion in different gynecological malignancies including SKOV-3, 
TOV-21G, and OVCAR-3 ovarian cancer cells (28, 36). PEITC is 
FigUre 2 | PeiTc causes rOs accumulation only in ovarian cancer 
cell lines, not in normal Ose (ovarian epithelial cells). Normal OSE and 
cancer cell lines (PA-1 and SKOV-3) were incubated with either vehicle or 
5 μM of PEITC for 12 or 24 h and ROS accumulation was detected by flow 
cytometry using 25 μM DCFH-DA (a). Cells were collected after PEITC 
treatment for 24 h, and GSH level was measured using glutathione assay kit 
(B). Values are means ± SEM (**P < 0.01 vs. vehicle control).
a well-tolerated phytochemical for normal cell both in vitro and 
in vivo studies (37). In the previous study, IC50 value of PEITC 
for endothelial cells was more than 100 μM, suggesting cancer 
cell-specific cell death by PEITC (28). PEITC is a well-known 
ROS inducer in cancer cells without any potential adverse effect 
on normal cells (30, 37). Consistent with previous studies, there 
was no significant effect on normal PBMC cells up to 10 μM con-
centration of PEITC in cell viability and ROS generation assays.
PEITC was used as ROS generator in pancreatic cancer cell 
line previously (30, 31). It was observed that PEITC treatment 
generated ROS in normal ovarian epithelial cell (T72) transfected 
with H-Ras (31). The present study also found increased level of 
ROS upon PEITC treatment in PA-1 and SKOV-3 cells. However, 
ROS accumulation was almost two times higher in SKOV-3 than 
in PA-1. High level of ROS can induce apoptosis, possibly through 
UPR pathway (38) which might explain the enhanced apoptotic 
cell death in SKOV-3. The difference of ROS production, UPR 
pattern, and apoptotic cell death between these two cell lines can 
be linked to the respective genotype in response to PEITC. In 
non-small cell lung cancer cells, mutated p53 expressing H1299 
cell line was shown to be more sensitive to PEITC than A549 
cells with wild-type p53 (39). By contrast, other study observed 
p53-dependent PEITC-induced apoptotic cell death in trans-
formed mouse epithelial cell, JB6 C1 41 (40). Thus, it remains to 
be determined whether p53 status is closely linked to the ROS-
UPR-mediated apoptosis in cancer cells.
One of the generating ROS mechanisms by PEITC is a deple-
tion of GSH. A role of GSH is known to detoxify ROS within 
cells. We assessed the GSH concentrations in these cell lines (PA-1 
and SKOV-3) after PEITC treatment for 24  h. It showed little 
increase in PA-1 cell line, while showing the significant decrease 
in SKOV-3 (P  =  0.019) (Figure  2B). Accumulating evidence 
reported that PEITC is rapidly conjugated with GSH, causing a 
depletion of the GSH pool, and subsequently inducing cell death 
through oxidative stress (23, 27). The depletion of GSH can be 
also achieved by targeting its synthesis. After serine synthesis in 
cells, serine is converted by a glycine intermediate to produce 
either inosine monophosphate (IMP) to generate purines (GMP 
and AMP) or GSH (41). Maddocks et al. found that the activated 
p53 induces transient p21-dependent cell cycle arrest allowing 
a recovery in GSH pools rather than IMP generation in p53+/+ 
colon cancer cell line. Conversely, these were not observed in 
either p53−/− or p21−/− isogenic cancer cells (42). It is known 
that p53 is involved in the regulation of antioxidant mechanism 
and energy metabolism (43). Under the stressed conditions, p53 
induces the expression of glutaminase, resulting in mitochondrial 
respiration and energy generation. In addition, glutaminase 
activated by p53 plays a role in antioxidant defense by increasing 
reduced GSH level, leading to a decrease of ROS level in cells 
(44). In our study, PEITC increased oxidative stress through ROS 
accumulation in ovarian cancer cells. However, a different pattern 
in GSH depletion and ROS generation was shown between PA-1 
with p53-wild type and SKOV-3 with p53-null type. Because p53 
activated by PEITC may supply a GSH pool to PA-1 (Figure S1 in 
Supplementary Material), PEITC-induced ROS generation was 
lower in PA-1 than SKOV-3, and GSH was significantly depleted 
in SKOV-3 due to an absence of p53. ROS imposed by PEITC 
FigUre 3 | PeiTc induces apoptosis in ovarian cancer cells. PA-1 
and SKOV-3 were incubated with vehicle or 5 μM of PEITC for 24 or 48 h. 
Apoptotic cell death was measured by Annexin V & PI straining using flow 
cytometry. Bar graph represents the mean percentage of apoptosis (a). 
PARP cleavage was detected in PA-1 and SKOV-3 cells after time 
dependent of PEITC treatment by western blotting (B). Cleaved 
PARP bands were determined by densitometry of bands using ImageJ 
software and, statistical analysis was performed by SPSS 20.0  
software (c). Values are means ± SEM (*P < 0.05, **P < 0.01 vs. the 
vehicle control).
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could activate ER stress sensors in different mechanism in PA-1 
and SKOV-3, contributing to induction of apoptosis. GSH–ROS 
antioxidant defense mechanism seems to contribute to different 
sensitivity of PEITC in ovarian cancer cells.
Phenethyl isothiocyanate showed apoptotic cell death both in 
PA-1 and SKOV-3 cell lines. These results are in agreement with 
a pervious study where PEITC induced apoptotic cell death in 
FigUre 4 | rOs scavenger, N-acetyl-L-cysteine (nac), inhibits 
PeiTc-induced apoptotic cell death. Ovarian cancer cell lines, PA-1 and 
SKOV-3, were incubated with vehicle, 10 mM NAC, 5 μM of PEITC and 
NAC with PEITC for 24 h, respectively. During treatment, NAC was added 
1 h before PEITC. Apoptotic cell death was detected by annexin V & PI 
straining using flow cytometry (a). PARP cleavage was detected in PA-1 
and SKOV-3 cells after 24 h of PEITC treatment, with or without the addition 
of NAC by western blotting (B). C, control (DMSO, the vehicle) group; N, 
NAC-treated group; P, PEITC-treated group for 24 h; N + P, NAC- and 
PEITC-treated group. NAC was treated for 1 h before 5 μM PEITC 
treatment. Cleaved PARP bands were determined by densitometry of bands 
using ImageJ software, and statistical analysis was performed by SPSS 
20.0 software (c). Values are means ± SEM (**P < 0.01 vs. the vehicle 
control).
these cell lines (32). However, in the present study, the apoptotic 
effect of PEITC was less prominent on PA-1 than on SKOV-3, 
suggesting comparative resistance of PA-1 to PEITC-induced 
apoptosis. This might be p53 related signaling pathway, the 
important one against cellular stress such as oxidative and DNA 
damaging stresses. The apoptotic cell death in these cell lines was 
reversed by the ROS scavenger, NAC. A number of studies are 
FigUre 5 | PeiTc induces unfolded protein response with attenuation of UPr by antioxidant, nac, in Pa-1 and sKOV-3 ovarian cancer cells.  
 (Continued)
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Cells were harvested at indicated hours after 5 μM PEITC treatment. Western 
blotting was performed to detect three arms of UPR (P-PERK, IRE1α, and ATF-6), 
molecular chaperone GRP78 and GADD153 in (a). With or without 1 h pretreated 
10 mM NAC. C, control (DMSO, the vehicle) group; N, NAC-treated group; P, 
PEITC-treated group for 24 h; N + P, NAC- and PEITC-treated group. NAC was 
treated for 1 h before 5 μM PEITC treatment (B). P-PERK, IRE1α, ATF-6, 
GADD153, and GRP78 bands were determined by densitometry of bands using 
ImageJ software. We analyzed statistical difference of triplicate experiments using 
ANOVA with Bonferroni’s post hoc test and performed using SPSS 20.0 software 
(c,D). Values are means ± SEM (*P < 0.05, **P < 0.01 vs. the vehicle control).
FigUre 5 | continued
July 2015 | Volume 5 | Article 1678
Hong et al. PEITC-induced UPR in ovarian cancer
Frontiers in Oncology | www.frontiersin.org
references
 1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin (2010) 
60(5):277–300. doi:10.3322/caac.20073 
 2. Ozols RF. Update on the management of ovarian cancer. Cancer J (2002) 
8(Suppl 1):S22–30. 
 3. Classe JM, Fontanelli R, Bischof-Delaloye A, Chatal JF. Ovarian cancer man-
agement. Practice guidelines for nuclear physicians. Q J Nucl Med Mol Imaging 
(2004) 48(2):143–9. 
 4. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem 
cells promote radioresistance by preferential activation of the DNA damage 
response. Nature (2006) 444(7120):756–60. doi:10.1038/nature05236 
 5. Kajiyama H, Mizuno M, Shibata K, Kawai M, Nagasaka T, Kikkawa F. 
Extremely poor postrecurrence oncological outcome for patients with 
recurrent mucinous ovarian cancer. Int J Clin Oncol (2014) 19(1):121–6. 
doi:10.1007/s10147-013-0522-0 
 6. Ozols RF. Recurrent ovarian cancer: evidence-based treatment. J Clin Oncol 
(2002) 20(5):1161–3. 
 7. Suh DH, Kim MK, No JH, Chung HH, Song YS. Metabolic approaches to 
overcoming chemoresistance in ovarian cancer. Ann N Y Acad Sci (2011) 
1229:53–60. doi:10.1111/j.1749-6632.2011.06095.x 
 8. Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, Birrer MJ. 
Identification of a potential ovarian cancer stem cell gene expression profile 
from advanced stage papillary serous ovarian cancer. PLoS One (2012) 
7(1):e29079. doi:10.1371/journal.pone.0029079 
 9. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded 
protein response. Nat Rev Mol Cell Biol (2007) 8(7):519–29. doi:10.1038/
nrm2199 
 10. Jager R, Bertrand MJ, Gorman AM, Vandenabeele P, Samali A. The unfolded 
protein response at the crossroads of cellular life and death during endoplasmic 
reticulum stress. Biol Cell (2012) 104(5):259–70. doi:10.1111/boc.201100055 
 11. Faitova J, Krekac D, Hrstka R, Vojtesek B. Endoplasmic reticulum stress 
and apoptosis. Cell Mol Biol Lett (2006) 11(4):488–505. doi:10.2478/
s11658-006-0040-4 
 12. Suh DH, Kim MK, Kim HS, Chung HH, Song YS. Unfolded protein response 
to autophagy as a promising druggable target for anticancer therapy. Ann N Y 
Acad Sci (2012) 1271:20–32. doi:10.1111/j.1749-6632.2012.06739.x 
 13. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk is essential for trans-
lational regulation and cell survival during the unfolded protein response. Mol 
Cell (2000) 5(5):897–904. doi:10.1016/S1097-2765(00)80330-5 
 14. Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, et al. ER stress 
(PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 
conversion, an essential step for autophagy formation. Cell Death Differ (2007) 
14(2):230–9. doi:10.1038/sj.cdd.4401984 
 15. Gardner BM, Pincus D, Gotthardt K, Gallagher CM, Walter P. Endoplasmic 
reticulum stress sensing in the unfolded protein response. Cold Spring Harb 
Perspect Biol (2013) 5(3):a013169. doi:10.1101/cshperspect.a013169 
 16. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic 
reticulum resident chaperone genes in the unfolded protein response. Mol Cell 
Biol (2003) 23(21):7448–59. doi:10.1128/MCB.23.21.7448-7459.2003 
 17. Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, 
et al. Coupling endoplasmic reticulum stress to the cell death program. An 
Apaf-1-independent intrinsic pathway. J Biol Chem (2002) 277(24):21836–42. 
doi:10.1074/jbc.M202726200 
 18. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, 
et al. CHOP is implicated in programmed cell death in response to impaired 
function of the endoplasmic reticulum. Genes Dev (1998) 12(7):982–95. 
doi:10.1101/gad.12.7.982 
 19. Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell 
Biol (2004) 14(1):20–8. doi:10.1016/j.tcb.2003.11.001 
 20. Lee J, Ozcan U. Unfolded protein response signaling and metabolic diseases. J 
Biol Chem (2014) 289(3):1203–11. doi:10.1074/jbc.R113.534743 
consistent with our results, ROS mediated cell death in many 
types of cancer cells (37, 45, 46).
We demonstrated the first evidence that PEITC-induced ROS 
activates UPR-mediated cell death in ovarian cancer cells. In 
several studies, PEITC has been shown to generate ROS (30, 31) 
triggering ER stress with subsequent UPR (11, 19, 38, 47). In the 
present study, upon PEITC treatment, BiP/GRP78, an ER stress 
marker, increased in a time-dependent manner in both cell lines. 
In SKOV-3, two sensors of UPR (P-PERK, IRE1α) became active 
with the upregulation of CHOP/GADD153. In PA-1, ATF-6, and 
PERK of UPR were activated, the CHOP/GADD153 was induced 
as early as 12 h after PEITC treatment. CHOP/GADD153 is an 
important pro-apoptotic transcription factor closely associated 
with UPR (48, 49), especially P-PERK-eIF2α pathway (49). Thus, 
it could be explained that increased level of CHOP/GADD153 
was observed in PA-1 and SKOV-3. NAC treatment along with 
PEITC reduced the expression of UPR sensors (P-PERK and 
IRE1α in SKOV-3, P-PERK and ATF-6 in PA-1) with decrease of 
CHOP/GADD153 expression in both cell lines. All these results 
taken together, the potential role of PEITC-induced ROS could 
play a critical role in UPR-mediated apoptosis of these ovarian 
cancer cells (Figure 5B).
In conclusion, this study strongly demonstrated that PEITC 
can cause cellular death through ROS-driven UPR activity. It 
induced apoptosis selectively in ovarian cancer cells and inhibited 
cellular proliferation along with the generation of ROS. Also, 
NAC treatment attenuated this effect suggesting that the response 
to the metabolic stress by PEITC could be regulated by ROS in 
ovarian cancer. Thus, this study showed the cancer-specific effect 
of PEITC on ovarian cancer cells. ROS and ER stress seem to be 
responsible for anticancer effects of PEITC on cancer cells and 
could be targeted for selective therapeutic strategy.
acknowledgments
This research was supported by the Priority Research Centers 
Program (2009-0093820) and BK21 plus program (5262-
20150100) through the National Research Foundation of Korea 
(NRF) funded by the Ministry of Education.
supplementary Material
The Supplementary Material for this article can be found online 
at http://journal.frontiersin.org/article/10.3389/fonc.2015.00167
July 2015 | Volume 5 | Article 1679
Hong et al. PEITC-induced UPR in ovarian cancer
Frontiers in Oncology | www.frontiersin.org
 21. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative 
stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal (2007) 
9(12):2277–93. doi:10.1089/ars.2007.1782 
 22. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, et al. 
PERK is required at the ER-mitochondrial contact sites to convey apopto-
sis after ROS-based ER stress. Cell Death Differ (2012) 19(11):1880–91. 
doi:10.1038/cdd.2012.74 
 23. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-
mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 
(2009) 8(7):579–91. doi:10.1038/nrd2803 
 24. Guilford JM, Pezzuto JM. Natural products as inhibitors of carcinogenesis. Expert 
Opin Investig Drugs (2008) 17(9):1341–52. doi:10.1517/13543784.17.9.1341 
 25. Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and 
human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol 
Res (2007) 55(3):224–36. doi:10.1016/j.phrs.2007.01.009 
 26. Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, et  al. 
Intake of cruciferous vegetables modifies bladder cancer survival. Cancer 
Epidemiol Biomarkers Prev (2010) 19(7):1806–11. doi:10.1158/1055-9965.
EPI-10-0008 
 27. Gupta P, Wright SE, Kim SH, Srivastava SK. Phenethyl isothiocyanate: a com-
prehensive review of anti-cancer mechanisms. Biochim Biophys Acta (2014) 
1846(2):405–24. doi:10.1016/j.bbcan.2014.08.003 
 28. Satyan KS, Swamy N, Dizon DS, Singh R, Granai CO, Brard L. Phenethyl 
isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing 
apoptosis: role of caspase and MAPK activation. Gynecol Oncol (2006) 
103(1):261–70. doi:10.1016/j.ygyno.2006.03.002 
 29. Wu X, Zhou QH, Xu K. Are isothiocyanates potential anti-cancer drugs? Acta 
Pharmacol Sin (2009) 30(5):501–12. doi:10.1038/aps.2009.50 
 30. Jutooru I, Guthrie AS, Chadalapaka G, Pathi S, Kim K, Burghardt R, et  al. 
Mechanism of action of phenethylisothiocyanate and other reactive oxygen 
species-inducing anticancer agents. Mol Cell Biol (2014) 34(13):2382–95. 
doi:10.1128/MCB.01602-13 
 31. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, et  al. 
Selective killing of oncogenically transformed cells through a ROS-mediated 
mechanism by beta-phenylethyl isothiocyanate. Cancer Cell (2006) 10(3):241–
52. doi:10.1016/j.ccr.2006.08.009 
 32. Chan DK, Miskimins WK. Metformin and phenethyl isothiocyanate com-
bined treatment in vitro is cytotoxic to ovarian cancer cultures. J Ovarian Res 
(2012) 5(1):19. doi:10.1186/1757-2215-5-19 
 33. Schnekenburger M, Grandjenette C, Ghelfi J, Karius T, Foliguet B, Dicato M, et al. 
Sustained exposure to the DNA demethylating agent, 2’-deoxy-5-azacytidine, 
leads to apoptotic cell death in chronic myeloid leukemia by promoting differen-
tiation, senescence, and autophagy. Biochem Pharmacol (2011) 81(3):364–78. 
doi:10.1016/j.bcp.2010.10.013 
 34. Gwak H, Haegeman G, Tsang BK, Song YS. Cancer-specific interruption of glu-
cose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 
axis in ovarian cancer cells. Mol Carcinog (2014). doi:10.1002/mc.22227 
 35. Kim SH, Song SH, Kim SG, Chun KS, Lim SY, Na HK, et al. Celecoxib induces 
apoptosis in cervical cancer cells independent of cyclooxygenase using 
NF-kappaB as a possible target. J Cancer Res Clin Oncol (2004) 130(9):551–60. 
doi:10.1007/s00432-004-0567-6 
 36. Loganathan S, Kandala PK, Gupta P, Srivastava SK. Inhibition of EGFR-
AKT axis results in the suppression of ovarian tumors in  vitro and in 
preclinical mouse model. PLoS One (2012) 7(8):e43577. doi:10.1371/journal.
pone.0043577 
 37. Xiao D, Powolny AA, Moura MB, Kelley EE, Bommareddy A, Kim SH, 
et al. Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger 
reactive oxygen species-mediated death of human prostate cancer cells. J Biol 
Chem (2010) 285(34):26558–69. doi:10.1074/jbc.M109.063255 
 38. Guan L, Han B, Li Z, Hua F, Huang F, Wei W, et al. Sodium selenite induces 
apoptosis by ROS-mediated endoplasmic reticulum stress and mitochondrial 
dysfunction in human acute promyelocytic leukemia NB4 cells. Apoptosis 
(2009) 14(2):218–25. doi:10.1007/s10495-008-0295-5 
 39. Pawlik A, Szczepanski MA, Klimaszewska A, Gackowska L, Zuryn A, Grzanka 
A. Phenethyl isothiocyanate-induced cytoskeletal changes and cell death in 
lung cancer cells. Food Chem Toxicol (2012) 50(10):3577–94. doi:10.1016/j.
fct.2012.07.043 
 40. Huang C, Ma WY, Li J, Hecht SS, Dong Z. Essential role of p53 in phenethyl 
isothiocyanate-induced apoptosis. Cancer Res (1998) 58(18):4102–6. 
 41. Tavana O, Gu W. The hunger games: p53 Regulates metabolism upon serine 
starvation. Cell Metab (2013) 17(2):159–61. doi:10.1016/j.cmet.2013.01.012 
 42. Maddocks OD, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, et al. 
Serine starvation induces stress and p53-dependent metabolic remodelling in 
cancer cells. Nature (2013) 493(7433):542–6. doi:10.1038/nature11743 
 43. Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated 
tumour suppression. Nat Rev Cancer (2014) 14(5):359–70. doi:10.1038/nrc3711 
 44. Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 
target gene regulating energy metabolism and antioxidant function. Proc Natl 
Acad Sci U S A (2010) 107(16):7455–60. doi:10.1073/pnas.1001006107 
 45. Wang Y, Wei S, Wang J, Fang Q, Chai Q. Phenethyl isothiocyanate inhibits 
growth of human chronic myeloid leukemia K562 cells via reactive oxygen 
species generation and caspases. Mol Med Rep (2014) 10(1):543–9. doi:10.3892/
mmr.2014.2167 
 46. Doudican NA, Wen SY, Mazumder A, Orlow SJ. Sulforaphane synergistically 
enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via 
stress-mediated pathways. Oncol Rep (2012) 28(5):1851–8. doi:10.3892/
or.2012.1977 
 47. Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic retic-
ulum stress-induced apoptosis. EMBO Rep (2006) 7(9):880–5. doi:10.1038/
sj.embor.7400779 
 48. Wang XZ, Lawson B, Brewer JW, Zinszner H, Sanjay A, Mi LJ, et al. Signals 
from the stressed endoplasmic reticulum induce C/EBP-homologous protein 
(CHOP/GADD153). Mol Cell Biol (1996) 16(8):4273–80. 
 49. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum 
stress. Cell Death Differ (2004) 11(4):381–9. doi:10.1038/sj.cdd.4401373 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2015 Hong, Uddin, Jo, Kim, Song, Suh, Kim and Song. This is an open-ac-
cess article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) or licensor are credited and that the original publication in this 
journal is cited, in accordance with accepted academic practice. No use, distribution 
or reproduction is permitted which does not comply with these terms.
